Within-Class Differences in Cancer Risk for Sulfonylurea Treatments in Patients With Type 2 Diabetes (ZODIAC-55) – A Study Protocol
BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3433-z
Full Text
Open PDFAbstract
Available in full text
Date
June 23, 2017
Authors
Publisher
Springer Science and Business Media LLC